Skip to main content
Livermore
Livermore
ZHEN

Inhibikase Therapeutics, Inc.

IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001750149

No open-market purchases or sales by Inhibikase Therapeutics, Inc. insiders were filed in the last 90 days; 105 institutions reported holding it in 13F filings for Q2 2026, worth $239.2M in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Inhibikase Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
54
+6 vs. Q2 2025
Shares held
55.0M
+452.4K (+0.8%) vs. Q2 2025
Total value
$89.0M
−$17.3M (−16.2%) vs. Q2 2025
New holders
8
16 more added
Sold out
2
15 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 54 institutions
Q1 2021: 9 institutionsQ2 2021: 14 institutionsQ3 2021: 21 institutionsQ4 2021: 26 institutionsQ1 2022: 24 institutionsQ2 2022: 22 institutionsQ3 2022: 24 institutionsQ4 2022: 19 institutionsQ1 2023: 17 institutionsQ2 2023: 14 institutionsQ3 2023: 13 institutionsQ4 2023: 11 institutionsQ1 2024: 12 institutionsQ2 2024: 12 institutionsQ3 2024: 11 institutionsQ4 2024: 31 institutionsQ1 2025: 47 institutionsQ2 2025: 48 institutionsQ3 2025: 54 institutionsQ4 2025: 74 institutionsQ1 2026: 104 institutionsQ2 2026: 105 institutions
Value heldQ3 2025: $89.0M
Q1 2021: $975.0KQ2 2021: $10.6MQ3 2021: $7.78MQ4 2021: $6.85MQ1 2022: $6.33MQ2 2022: $2.49MQ3 2022: $2.78MQ4 2022: $719.4KQ1 2023: $2.91MQ2 2023: $2.69MQ3 2023: $597.6KQ4 2023: $298.9KQ1 2024: $443.8KQ2 2024: $1.02MQ3 2024: $1.12MQ4 2024: $162.7MQ1 2025: $112.7MQ2 2025: $106.3MQ3 2025: $89.0MQ4 2025: $218.2MQ1 2026: $193.4MQ2 2026: $239.2M
Institutions holding IKT and their total value by quarter
QuarterHoldersValue
Q2 2026105$239.2M
Q1 2026104$193.4M
Q4 202574$218.2M
Q3 202554$89.0M
Q2 202548$106.3M
Q1 202547$112.7M
Q4 202431$162.7M
Q3 202411$1.12M
Q2 202412$1.02M
Q1 202412$443.8K
Q4 202311$298.9K
Q3 202313$597.6K
Q2 202314$2.69M
Q1 202317$2.91M
Q4 202219$719.4K
Q3 202224$2.78M
Q2 202222$2.49M
Q1 202224$6.33M
Q4 202126$6.85M
Q3 202121$7.78M
Q2 202114$10.6M
Q1 20219$975.0K

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Inhibikase Therapeutics, Inc.; share changes are against Q2 2025.

Institutions holding IKT in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Sands Capital Ventures, LLC10,950,000$17.7M3.89%00.0%Unchanged
Soleus Capital Management, L.P.6,325,000$10.2M0.55%00.0%Unchanged
Fairmount Funds Management LLC6,125,000$9.92M0.89%00.0%Unchanged
Perceptive Advisors LLC5,421,568$8.78M0.25%−10,725−0.2%Reduced
Commodore Capital LP5,397,488$8.74M0.43%00.0%Unchanged
ADAR1 Capital Management, LLC5,247,603$8.50M0.84%+125,498+2.5%Added
Vanguard Group Inc3,273,339$5.30M0.00%+48,969+1.5%Added
BlackRock, Inc.3,075,186$4.98M0.00%+347,018+12.7%Added
Blackstone Group Inc.2,638,276$4.27M0.02%00.0%Unchanged
Nantahala Capital Management, LLC2,190,000$3.55M0.22%00.0%Unchanged
Geode Capital Management, LLC1,112,574$1.80M0.00%+45,874+4.3%Added
Stonepine Capital Management, LLC735,019$1.19M0.97%+1,226+0.2%Added
State Street Corp507,749$822.6K0.00%+109,937+27.6%Added
Northern Trust Corp374,336$606.4K0.00%−18,380−4.7%Reduced
Blair William & Co152,953$247.8K0.00%−4,000−2.5%Reduced
Charles Schwab Investment Management Inc152,298$246.7K0.00%00.0%Unchanged
Bank of New York Mellon Corp138,667$224.6K0.00%+6,194+4.7%Added
UBS Group AG136,280$220.8K0.00%+97,606+252.4%Added
FMR LLC105,770$171.3K0.00%−38,469−26.7%Reduced
Barclays PLC85,578$138.6K0.00%−24,674−22.4%Reduced
Deutsche Bank AG80,496$130.4K0.00%+80,496New
Nuveen, LLC78,659$127.4K0.00%00.0%Unchanged
Citadel Advisors LLC71,670$116.1K0.00%+71,670New
Rhumbline Advisers57,551$93.2K0.00%−973−1.7%Reduced
Morgan Stanley56,019$90.8K0.00%−43,659−43.8%Reduced
JPMorgan Chase & Co49,937$80.9K0.00%+21,358+74.7%Added
New York State Common Retirement Fund47,900$77.6K0.00%−12,800−21.1%Reduced
Wells Fargo & Company45,745$74.1K0.00%+7,419+19.4%Added
Susquehanna International Group, LLP45,605$73.9K0.00%−337,466−88.1%Reduced
Invesco Ltd.33,034$53.5K0.00%+2,322+7.6%Added
Intech Investment Management LLC31,918$51.7K0.00%+512+1.6%Added
Price T Rowe Associates Inc30,606$50.0K0.00%00.0%Unchanged
Mirae Asset Global ETFs Holdings Ltd.27,963$45.3K0.00%−5,060−15.3%Reduced
Police & Firemen's Retirement System of New Jersey17,638$28.6K0.00%00.0%Unchanged
Bank of America Corp17,102$27.7K0.00%−2,114−11.0%Reduced
Caxton Corp16,393$26.6K0.12%00.0%Unchanged
BNP Paribas Arbitrage, SA15,640$25.3K0.00%+6,458+70.3%Added
Virtu Financial LLC13,446$22.0K0.00%+13,446New
Voya Investment Management LLC13,146$21.3K0.00%−5,609−29.9%Reduced
Goldman Sachs Group Inc10,735$17.4K0.00%+10,735New
Buckingham Strategic Partners10,708$17.3K0.00%00.0%Unchanged
ProShare Advisors LLC10,341$16.8K0.00%−2,060−16.6%Reduced
Russell Investments Group, Ltd.7,702$12.5K0.00%+7,702New
Tower Research Capital LLC (TRC)7,046$11.4K0.00%+6,946+6,946.0%Added
Ameritas Investment Partners, Inc.6,174$10.0K0.00%00.0%Unchanged
Legal & General Group Plc5,504$8.89K0.00%00.0%Unchanged
Sterling Capital Management LLC3,827$6.20K0.00%+2,322+154.3%Added
California State Teachers Retirement System3,776$6.12K0.00%+3+0.1%Added
Amalgamated Bank2,065$3.00K0.00%00.0%Unchanged
Citigroup Inc902$1.46K0.00%−19,491−95.6%Reduced
Royal Bank of Canada663$1.00K0.00%−3,924−85.5%Reduced
The PNC Financial Services Group, Inc.90$1460.00%+90New
SRS Capital Advisors, Inc.86$1390.00%+86New
CWM, LLC19$00.00%+19New
LMR Partners LLP0$00.00%−31,092−100.0%Sold out
Raymond James Financial Inc0$00.00%−1,000−100.0%Sold out